Navigation Links
Inclinix Announces New Patent for Expert System Platform
Date:3/10/2008

WILMINGTON, N.C., March 10 /PRNewswire/ -- Inclinix, Inc., an enrollment contract research organization (CRO) and provider of clinical trial recruitment solutions, announced today that it has received a patent for its Expert System Platform (ESP). ESP is a software system that guides interview questions during patient qualification for clinical trials of new drugs or medical devices.

Inclinix advertises to recruit patients into clinical trials. Respondents to Inclinix advertising answer questions on a Web site or when interacting via phone with Inclinix TeleMEDICINE(TM) Contact Center representatives. The questions posed to respondents determine if the respondents fit the inclusion and exclusion criteria from the trial sponsor, usually a pharmaceutical company.

ESP dynamically organizes questions for the interview, changing question order or removing questions depending on the answers. ESP is particularly helpful for simultaneous trials. The system can automatically switch the prospective trial candidate to questions for a sponsor's second, third or fourth trial if he or she does not qualify for the first one.

ESP inventor and Inclinix Chief Operating Officer Chris Sleat said: "The way that the system is built turns the previous interviewing automation processes and logic on its head. With ESP, the data defines the screening logic, so users do not have to think about the structure or dependencies of the interview. ESP is vastly superior to a static interview script."

ESP includes the ability to leverage data from prior volunteers who have elected to be included in a database for consideration in future trials. EPS works well in combination with internal reporting systems.

ESP also supports novel medical questionnaires, and the platform has been used in homeland security applications. The design supports interviewing patients in terrorist incidents to see if they are victims of weapons of mass destruction. The ESP system initiates questions about multiple possible weapons exposure and then narrows the inquiry based on answers.

The patent number for the Expert System Platform is 7330842.

About Inclinix

Founded in 1999, Inclinix, Inc., is the industry's Enrollment CRO. Inclinix's IQM(TM) Intelligent Enrollment process uses technology to amplify traditional services and is proven to accelerate trials for pharmaceutical, biotechnology and medical-device organizations. In addition to its clinical research-related offerings, Inclinix provides strategic medical marketing communications and adherence services to the healthcare industry. For more information on Inclinix, visit http://www.inclinix.com


'/>"/>
SOURCE Inclinix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Market - Forecast to 2022" report to their offering. ... method for the patients with kidney failure, it replaces the ... from the patient,s blood and thus the treatment helps to ... chloride in balance. Increasing number of ESRD ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
(Date:6/23/2016)... 2016 Bracket , a leading clinical trial ... clinical outcomes platform, Bracket eCOA (SM) 6.0, at the ... – 30, 2016 in Philadelphia , Pennsylvania.  ... Assessment product of its kind to fully integrate with RTSM, ... eCOA 6.0 is a flexible platform for electronic clinical outcomes ...
Breaking Medicine Technology:
(Date:6/27/2016)... , ... June 27, 2016 , ... "FCPX editors can ... inside of Final Cut Pro X," said Christina Austin - CEO of Pixel Film ... Final Cut Pro X users can now reveal the media of their ...
(Date:6/27/2016)... , ... June 27, 2016 , ... ... edge technology to revolutionize the emergency ambulance transport experience for the millions of ... of how Uber has disrupted the taxi industry through the use of technology. ...
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A Forever Recovery, ... Festival and World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility ... home to some of the world’s leading providers of cereal and other breakfast foods. ...
(Date:6/26/2016)... ... ... Kasmer, a legally blind and certified personal trainer is helping to develop a weight loss ... plans to fix the two major problems leading the fitness industry today:, ... , They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
Breaking Medicine News(10 mins):